BARDA within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
Business Model: Goverment
Revenue: $0
Employees: 201-500
Address:
City: Washington
State: District of Columbia
Zip:
Country: United States
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2017 | Velico Medical | Venture Round | 19M |
9/2019 | BioFactura | Grant | 67.4M |
12/2019 | Qpex Biopharma | Grant | 20M |
4/2020 | RxSight | Venture Round | 9.6M |
3/2022 | Visby Medical | Grant | 25.5M |
10/2022 | OraSure Technologies | Grant | 10.4M |
9/2016 | Sanofi Pasteur | Grant | 43.2M |
7/2021 | Cepheid | Grant | 27M |
9/2020 | Vedanta Biosciences | Grant | 76.9M |
1/2023 | Sabin Vaccine Institute | Grant | 35M |
3/2022 | The Stevanato Group | Grant | 95M |
7/2019 | Integrated BioTherapeutics | Grant | 1.6M |
2/2021 | Visby Medical | Grant | 12.3M |
9/2008 | SIGA Technologies | Grant | 55M |
8/2022 | Spectral MD | Grant | 8.2M |
9/2021 | Spectral MD | Grant | 18.8M |
1/2022 | Cue | Grant | - |
10/2020 | First Light Diagnostics | Grant | 4M |
4/2020 | Cue | Grant | 13M |
9/2014 | Spectral MD | Grant | 26M |
3/2020 | MediWound | Grant | 5.5M |
4/2020 | Emergent BioSolutions | Grant | 14.5M |
6/2020 | Corning | Grant | 204M |
9/2022 | Sabin Vaccine Institute | Grant | 21.8M |
6/2021 | SeLux Diagnostics | Grant | 14.6M |
6/2016 | Terumo | Grant | 17.4M |
6/2020 | QuidelOrtho | Grant | - |
4/2020 | Paratek Pharmaceuticals | Post-IPO Equity | - |
8/2019 | Altimmune | Grant | 3.7M |
12/2019 | First Light Diagnostics | Grant | 4.3M |
8/2022 | Everglade Consulting | Grant | 39M |
7/2019 | Spectral MD | Grant | 27.3M |
9/2016 | Moderna Therapeutics | Grant | 8M |
10/2020 | Vaxxas | Grant | 22M |
8/2022 | Arcturus Therapeutics | Grant | 63.2M |
9/2022 | Enalare Therapeutics | Grant | 50.3M |
3/2020 | GenMark Diagnostic | Grant | - |
4/2020 | Moderna Therapeutics | Grant | 483M |
4/2020 | SeLux Diagnostics | Grant | 9.6M |
5/2022 | BugSeq Bioinformatics | Grant | - |
7/2020 | Moderna Therapeutics | Grant | 472M |
7/2016 | Soligenix | Grant | 634k |
4/2020 | Vela Diagnostics Pte. Ltd. | Grant | 225k |
1/2020 | Summit Therapeutics | Post-IPO Equity | 8.8M |
4/2021 | Spectral MD | Grant | 20.6M |
7/2022 | SeLux Diagnostics | Unattributed | 8M |
8/2021 | Basilea Pharmaceutica | Grant | 4.3M |
1/2022 | Opiant Pharmaceuticals | Grant | 2M |
1/2022 | Spero Therapeutics | Grant | 12.9M |
8/2018 | Summit Therapeutics | Post-IPO Equity | 2M |
9/2022 | T2 Biosystems | Grant | 3.7M |
9/2019 | T2 Biosystems | Grant | 69M |
7/2022 | SeLux Diagnostics | Grant | 0 |
5/2022 | BugSeq Bioinformatics | Grant | - |
3/2022 | Visby Medical | Grant | 0 |
3/2022 | The Stevanato Group | Grant | 0 |
1/2022 | Opiant Pharmaceuticals | Grant | 0 |
1/2022 | Spero Therapeutics | Grant | 0 |
1/2022 | Cue | Grant | - |
9/2021 | Spectral MD | Grant | 0 |
8/2021 | Basilea Pharmaceutica | Grant | 0 |
7/2021 | Cepheid | Grant | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|